Extravasation injury from anthracycline injection

Extravasation injury from anthracycline injection is a severe iatrogenic complication arising when DNA-intercalating anthracycline antineoplastics inadvertently leak from the vascular compartment into the perivascular soft tissues during intravenous administration

Extravasation injury from anthracycline injection is a severe iatrogenic complication arising when DNA-intercalating anthracycline antineoplastics inadvertently leak from the vascular compartment into the perivascular soft tissues during intravenous administration Primarily affecting the integumentary and musculoskeletal systems of oncology patients, this condition is characterized by the potent vesicant properties of anthracyclines As dying cells lyse, the drug is re-released into surrounding t...

Extravasation injury from anthracycline injection is a severe iatrogenic complication arising when DNA-intercalating anthracycline antineoplastics inadvertently leak from the vascular compartment into the perivascular soft tissues during intravenous administration Extravasated drug molecules rapidly enter local healthy cells, complex with DNA and topoisomerase II, and generate destructive free radicals As dying cells lyse, the drug is re-released into surrounding tissue, causing a self-perpetuat...

Primarily affecting the integumentary and musculoskeletal systems of oncology patients, this condition is characterized by the potent vesicant properties of anthracyclines As dying cells lyse, the drug is re-released into surrounding tissue, causing a self-perpetuating cycle of progressive tissue damage clinically marked by intense pain, erythema, induration, and extensive deep-tissue necrosis or chronic ulceration

Extravasated drug molecules rapidly enter local healthy cells, complex with DNA and topoisomerase II, and generate destructive free radicals

Extravasated drug molecules rapidly enter local healthy cells, complex with DNA and topoisomerase II, and generate destructive free radicals